California · Nonprofit
PALO ALTO VETERANS INSTITUTE FOR RESEARCH
PALO ALTO VETERANS INSTITUTE FOR RESEARCH (California) receives grants from 34 organizations whose IRS filings report $20,142,266 to it, the largest being American Heart Association Inc ($5,236,818). 24 of them have funded it in more than one year.
- Revenue FY2025
- $36M
- Funders on record
- 34
- Grants received
- $20M
- Net assets
- $8.0M
What Palo Alto Veterans Institute for Research does
Mission
Pavir's mission is advancing veterans and public health through innovative research. Pavir works with more than 100 principal investigators and 200 research staff to support basic science, clinical and health services research to realize its mission. Pavir's diverse studies span the entire spectrum of health research from the investigation of diseases in the laboratory through testing new drug treatments and developing improved models of health care delivery to looking at outcomes both individually and on a large scale. Pavir's research addresses health challenges that have been faced especially by veterans, including post-traumatic stress disorder, traumatic brain injury, geriatric medicine, rehabilitation, sleep and other veterans and public health issues. Pavir's investigators have appointments at the va palo alto health care system and most also hold appointments at the stanford university school of medicine.
As stated on its FY2025 Form 990.
Programs
Clinical translation of allogeneic regenerative cell therapy for white matter stroke and vascular dementia. Principal investigator: irene lorenzo llorente, ph.d.stroke is the leading cause of adult disability and the second leading cause of dementia. White matter stroke (wms) constitutes up to 30% of all stroke subtypes and is a distinct process from "large artery stroke." wms begins as small infarcts in deep penetrating blood vessels in the brain but progresses, accumulates, and expands from preexisting lesions into adjacent white matter to produce hemiparesis with incomplete recovery, gait abnormalities, cognitive decline, and executive dysfunction characteristic of vascular dementia (vad). Unlike large artery stroke, wms does not damage neuronal cell bodies but primarily affects axonal tracts and glial cells. A cell-based therapy capable of replacing lost glia and inducing structural repair in wms/vad holds great promise. We have developed a unique allogeneic human induced pluripotent stem cell (hipsc)-derived glial enriched progenitor (gep) cell therapy product for the treatment of wms and vad. Preclinical studies demonstrate that hipsc-geps transplanted into the brain after…
$1,310,697 spent5% of program spendingNovel lymphocyte chemoattractant receptor and ligand. Principal investigator: eugene butcher, m.d.we have identified a novel lymphocyte chemoattractant receptor and its chemoattractant ligand, selectively expressed in lung, airways, upper gi tract, genitourinary mucosae and mucosa-associated glands including the pancreas and salivary glands. Aim 1: we will mechanistically probe the receptor-ligand interactions focusing on the specificity and signaling pathways activated by the novel receptor and its role as a lymphocyte vs myeloid cell chemotactic receptor. Structure-function studies will identify ligand domains for receptor binding and activation. Aim 2: will define the regulation of the receptor in the mouse, and its role in lymphocyte population of and homing to non-lymphoid tissues during homeostasis and in the setting of chronic multi-organ autoimmune inflammation. The roles of the pathway in immune cell development will be probed in mixed bone marrow chimeras in which receptor-deficient vs wild type stem cells compete for reconstitution of immune compartments in lymphoid and non-lymphoid tissues. Aim 3: will elucidate the tissue- and cell subset-specific expression of the…
$1,238,218 spent4% of program spendingAll of us research program. Principal investigators: philip tsao, ph.d. The all of us research program (all of us) is a large collaborative initiative sponsored by the national institutes of health (nih). All of us includes a consortium of awardees from multiple institutions, including the department of veterans affairs. All of us is working to improve healthcare through research by building a diverse database of participant self-report information, biospecimens, and electronic health records that can inform future research on a variety of health conditions. Va participation in all of us is overseen by two co-pis, located at the va palo alto healthcare system and the va boston healthcare system. These two institutions serve as the coordinating centers for va responsible for centralized recruitment, engagement campaigns, and compliance with program requirements.
$1,062,166 spent4% of program spendingPavir is privileged to work with a large community of uniquely talented medical researchers across a broad spectrum of research areas as we fulfill our mission of advancing veterans and public health through innovative research. The range of research activities is broad and includes special emphasis on major disease categories, all of which are prevalent in the va's patient population. These include cardiovascular medicine, mental health, chronic inflammatory disease, stem cell/regenerative medicine, pain, sleep disorders, and many others. In addition to disease specific research, pavir is engaged in supporting research aimed at enhancing health care. Pavir's research portfolio includes comparative studies in which research teams are learning which treatments are superior to others, how to augment or improve standard of care, as well as how to enhance the operation of health care. Furthermore, pavir is supporting educational activities, especially in areas of advancing clinical care for veterans and fostering the professional development of our expert staff.
$24,180,777 spent$10,144,436 earned by the program87% of program spending
The 4 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $27,791,858.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2022 to 2023, from $16M to $21M (+32%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2017 76% · 2018 81% · 2019 76% · 2020 78% · 2021 77% · 2022 56% · 2023 60% · 2024 62% · 2025 59%. Grants only. Government contracts and fees sit inside program revenue.
71% of PALO ALTO VETERANS INSTITUTE FOR RESEARCH’s revenue is contributions — more reliant on donations than three-quarters of its peers (7% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 9 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Elaine Staats
Chief executive officer
Board chair
Odette Harris
Director / board chair
As listed on its FY2025 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 8 funders to 14 funders, grant income rose $1.0M → $5.3M.
5 of 34 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 7% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of PALO ALTO VETERANS INSTITUTE FOR RESEARCH’s funders (the co-funder graph). Top 30 of 34 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
PALO ALTO VETERANS INSTITUTE FOR RESEARCH has a broad base — no single funder exceeds 26% of grant income, and it takes 3 funders to reach half.
the vertical line marks half of all grant income — 3 funders to its left
73% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund PALO ALTO VETERANS INSTITUTE FOR RESEARCH.
Largest funder’s share by year: 2017 27% · 2018 21% · 2019 27% · 2020 42% · 2021 24% · 2022 58% · 2023 61% — growing more concentrated.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
67% of PALO ALTO VETERANS INSTITUTE FOR RESEARCH's funders are still giving 3 years after their first grant; 71% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
PALO ALTO VETERANS INSTITUTE FOR RESEARCH draws 97% of its grant income from funders outside California, across 16 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $1.5M arriving through sponsors registered in 5 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
PALO ALTO VETERANS INSTITUTE FOR RESEARCH holds deeper cash reserves than three-quarters of the 2,843 health nonprofits its size.
this organization peer median middle 50% of peers· 2,843 health nonprofits $10M–$100M, FY2025
Government funding PALO ALTO VETERANS INSTITUTE FOR RESEARCH receives
Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $155.6M on record.
- Department of Health and Human Services$118.0M
- Department of Defense$34.6M
- Department of Homeland Security$1.5M
- National Science Foundation$1.4M
Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.
Organizations like PALO ALTO VETERANS INSTITUTE FOR RESEARCH
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In California
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
84% of spending goes to programs.
Governance
Footprint & structure
Files a return copy in 1 state
Part of a family of 1 related entity
- Va Palo Alto Health Care System · exempt
Screen this organization
A dated, signed PDF of the compliance screen for PALO ALTO VETERANS INSTITUTE FOR RESEARCH: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds PALO ALTO VETERANS INSTITUTE FOR RESEARCH?
- PALO ALTO VETERANS INSTITUTE FOR RESEARCH (California) receives grants from 34 organizations whose IRS filings report $20,142,266 to it, the largest being American Heart Association Inc ($5,236,818). 24 of them have funded it in more than one year.
- How many funders does PALO ALTO VETERANS INSTITUTE FOR RESEARCH have?
- IRS filings report 34 organizations giving $20,142,266 in grants to PALO ALTO VETERANS INSTITUTE FOR RESEARCH, 24 of which have funded it in more than one year.
- Who is the largest funder of PALO ALTO VETERANS INSTITUTE FOR RESEARCH?
- American Heart Association Inc is the largest funder on record, with $5,236,818 in grants. The full list of funders is on this page.
- How can an organization like PALO ALTO VETERANS INSTITUTE FOR RESEARCH find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Palo Alto Veterans Institute for Research →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 34 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing